BISMUSAL - bismuth subsalicylate suspension 
Sparhawk Laboratories, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BISMUSAL SUSPENSION Anti-Diarrheal Liquid

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

FOR ORAL USE ONLY

SHAKE WELL BEFORE USING

INDICATIONS

A palatable oral suspension for use as an aid in the control of simple diarrhea in cattle, horses and dogs.

CONTRAINDICATION

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs- 1 to 3 tablespoons

Calves- 3 to 4 ounces

Foals- 3 to 4 ounces

Cattle and Horses- 6-10 fl. ozs.

This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact veterinarian.

COMPOSITION

Bismuth Subsalicylate ........... 1.75%

in a palatable aqueous suspension.  Flavoring and coloring added.

Store at room temperature not above 37°C (98.6°F)

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

SLI Bismusal

BISMUSAL 
bismuth subsalicylate suspension
Product Information
Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58005-700
Route of Administration ORAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE 66.2 g  in 3.785 L
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:58005-700-07 3.785 L in 1 JUG
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 02/18/2009
Labeler - Sparhawk Laboratories, Inc. (147979082)

Revised: 10/2017
Document Id: 4881507b-2119-4757-8cde-e5730c3ff562
Set id: d685ed87-5059-4a68-8cfa-2cea2f7ed749
Version: 9
Effective Time: 20171011
 
Sparhawk Laboratories, Inc.